MedPath

A study of prevalence and developing mechanisms of insulin-derived amyloidosis in insulin-treated patients with diabetes

Not Applicable
Recruiting
Conditions
Diabetes mellitus
Registration Number
JPRN-UMIN000021027
Lead Sponsor
Department of Metabolism and Endocrinology, Tokyo Medical University Ibaraki Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) Contraindication to MRI

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of insulin-derived amyloidosis
Secondary Outcome Measures
NameTimeMethod
Risk factors for incidence
© Copyright 2025. All Rights Reserved by MedPath